Resverlogix and Medison Pharma Ltd. Announce Strategic Licensing Agreement
08. Januar 2018 08:57 ET
|
Resverlogix Corp
CALGARY, Alberta, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) today announced that it has entered into a licensing agreement with Medison...